DarioHealth Corp. 8-K Summary: 2025 Annual Meeting Results
Business Context and Reporting Period
This Form 8-K reports the final voting results of DarioHealth Corp.'s 2025 Annual Meeting of Stockholders held on July 23, 2025. The company is incorporated in Delaware and trades on The Nasdaq Capital Market under the symbol DRIO.
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report focuses exclusively on corporate governance and capital structure votes.
Material Changes and Voting Results
Stockholders approved five key proposals:
- Election of Directors: All six nominees (Hila Karah, Dennis Matheis, Dennis M. McGrath, Erez Raphael, Yoav Shaked, Lawrence Leisure, and Adam K. Stern) were elected. Vote counts ranged from approximately 28.7 million to 30.6 million "For" votes.
- Ratification of Auditors: Kesselman & Kesselman (PricewaterhouseCoopers International Limited) was ratified as the independent auditor for the fiscal year ending December 31, 2025, with 40,147,602 "For" votes.
- Equity Compensation Plan Amendment: The 2020 Equity Compensation Plan was amended to increase the share pool annually by 6% of outstanding shares for years 2026 through 2030 and to authorize Restricted Stock Units (RSUs). This passed with 27,495,788 "For" votes.
- Reverse Stock Split: Shareholders authorized the Board to effect a reverse stock split at a ratio between 2-for-1 and 25-for-1, to be implemented by September 15, 2025. This passed with 38,540,911 "For" votes.
- Increase in Authorized Shares: The number of authorized common shares was increased from 160 million to 400 million. This passed with 35,418,547 "For" votes (voting as a single class).
Guidance, Outlook, and Risks
The filing text does not provide management commentary, financial guidance, or specific risk factors beyond the standard disclosure of the voting outcomes. The authorization of a reverse stock split implies a strategic move to adjust the share price, though the specific ratio remains at the Board's discretion.
Investor Verification Checklist
- Verify the specific reverse stock split ratio selected by the Board before the September 15, 2025 deadline.
- Confirm the impact of the 6% annual equity plan increase on future dilution.
- Review the company's subsequent filings for the implementation details of the reverse split and the updated authorized share count.
- Check for any dissenting shareholder actions regarding the significant "Against" votes on the Equity Plan (approx. 3.3 million) and Authorized Shares increase (approx. 4.9 million).